Journal of Biomolecular Research & Therapeutics (JBMRT)

Journal of Biomolecular Research and Therapeutics is a rigid single blind peer reviewed journal serving the International Scientific Community. It provides a wide range of research in analyzing biomolecules includes both macro and micromolecules and use of it in treating different diseases. The journal mainly focuses on Biomolecular research and use of biomolecules and different technologies like Nano-Technology in the treatment of various forms of Carcinoma like Basal cell carcinoma, Squamous cell carcinoma, Renal cell carcinoma, Invasive ductal carcinoma, Adenoma carcinoma. It also focuses on Organic biomolecules, Biomolecular structures, Biomolecular engineering, Biomolecular modelling, Biomolecular interactions, Biomolecular techniques, Biomolecular crystellography, Biomolecular screening, NMR in Biomolecular research, Biomolecular physics, Biomolecular therapeutics, Biomolecular therapeutics companies, Enzyme-linked immunosorbent assay, Bioconjugation, Biomimetic therapeutics, Protein biosynthesis, Electroporation, Lipid therapy, Recombinant protein therapeutics, Bio-immobilization, Bioreactor, Polymer therapeutics and Smart polymers to achieve its aim. Biomolecular Research & Therapeutics is an Open Access journal that aims to publish the most complete and reliable source of information on the discoveries and current developments as original articles, review articles, mini-reviews, case reports, short communications, commentary, opinion articles etc. in all areas of the field and make them available online to the researchers world wide without any subscriptions only after rigid peer-review process to maintain the International Standards.

Journal of Biomolecular Research & Therapeutics (JBMRT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Biomolecular Research, Molecular Biology, Therapeutics, Nanomedicine, Cancer Biology, Biomolecular Engineering, Structural Biology, Biophysics, Biotechnology, Drug Development , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2167-7956, Established: 2012, Impact Factor: 0.31
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE